Palbociclib in combination with letrozole as first-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase 2 study. 2. Oktober 2018 Welslau, M., Zaiss, M., Söling, U., Untch, M., Müller, L., Lüftner, D., Meiler, J., Welt, A., Sahlmann, J., Houet, L., Runkel, E., Vannier, C., Marschner, N., 2018. Oncol Res Treat 41 (suppl 4)(P919). An observational study to evaluate the effectiveness of OnLife® in improving chemotherapy-induced peripheral neuropathy in patients with colon or breast cancer after end of adjuvant therapy: Design of the STEFANO trial. Zaiss, M., Uhlig, J., Zahn, M.-O., Decker, T., Lehmann, H., Harde, J., Hogrefe, C., Vannier, C., Marschner, N., 2018. Oncol Res Treat 41 (suppl 4)(P945). Weiterlesen First-line pazopanib in poor-risk patients with metastatic renal cell carcinoma. Staehler, M., Panic, A., Merling, M., Vannier, C., Hermann, E., Hogrefe, C., Potthoff, K., Grünwald, V., 2018. Oncol Res Treat 41 (suppl 4)(P606). Weiterlesen